What other stocks do shareholders of (VTAE) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (VTAE) investors own include Bausch Health Companies (BHC) , Mallinckrodt (MNK) , Zosano Pharma (ZSAN) , Akari Therapeutics (AKTX) , Aquinox Pharmaceuticals (AQXP) , Sangamo Therapeutics (SGMO) , Trevena (TRVN) and Arbutus Biopharma (ABUS) .

NASDAQ:VTAE

(VTAE) (VTAE) Stock Price, News & Analysis

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)

Free VTAE Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $21.00
▼
$21.00
50-Day Range: N/A
52-Week Range: $4.08
▼
$21.03

Volume: N/A
Average Volume: 763,870 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (VTAE) alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About (VTAE) Stock (NASDAQ:VTAE)

Vitae Pharmaceuticals, Inc. is a biotechnology company. The Company is focused on discovering and developing small molecule drugs for diseases. It is engaged in developing a portfolio of product candidates through Contour, its structure-based drug discovery platform. The Company's product candidates include VTP- 43742 for the treatment of psoriasis, as well as multiple other autoimmune disorders. The Company completed approximately two Phase I studies with VTP-43742. Its VTP-38543, a second product candidate is in a Phase IIa proof-of-concept clinical trial for the treatment of atopic dermatitis. Its VTP-36951 is for the treatment and prevention of Alzheimer's disease, or Alzheimer's. VTP-43742, the Company's wholly owned clinical candidate in an on-going Phase IIa proof-of-concept trial in psoriasis, is an orally active small molecule inhibitor of Retinoic acid-receptor (RAR)-Related Orphan Receptor gamma-t (RORgt) activity for the treatment of various autoimmune disorders.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

VTAE Stock News Headlines

November 27, 2023 | msn.com

Michigan, Washington move up in top five of US LBM Coaches Poll, while Ohio State tumbles

June 9, 2023 | msn.com

Georgia tax revenue falls nearly 8% in May, officials say

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 5, 2023 | msn.com

Canada can play a big role in addressing growing food insecurity, Nutrien CEO says

February 26, 2023 | msn.com

Turkey rocked by another quake — the third in 2 weeks

January 3, 2023 | msn.com

"Maybe" - Sky Sports man hints at "minutes" for Arsenal talent in FA Cup

December 21, 2022 | msn.com

How private business jet subscriptions are changing luxury travel – VistaJet and Jettly mean holidaying like a celebrity with no waiting, Michelin-star food and only 24 hours ...

December 5, 2022 | msn.com

Clayton Kershaw signs 1-year deal to return to Dodgers

April 19, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

November 9, 2022 | msn.com

Tropical Storm Nicole Closures, Cancellations In Sarasota, Bradenton

September 3, 2022 | thestreet.com

Vitae Pharmaceuticals (VTAE) Stock Skyrockets on Positive Trial Results

August 10, 2022 | msn.com

Independence Island and Bailey's Island are on the market: here's a brief history

August 10, 2022 | msn.com

‘Hell on earth’: Personal stories from UNT’s North Texas Heat Research Project

April 16, 2022 | nasdaq.com

Interesting CIEN Put And Call Options For June 17th

April 8, 2022 | investing.com

Vitae Pharmaceuticals Inc (VTAE)

March 10, 2022 | msn.com

‘They were shooting civilians’: Ukraine refugees saw abuses

January 22, 2022 | thestreet.com

Vitae Pharmaceuticals (VTAE) Stock Downgraded on $639 Million Allergan Deal

August 27, 2021 | dailymail.co.uk

Ashley Graham puts her baby bump on display in bright pink bikini as she enjoys family time

August 19, 2021 | msn.com

Northampton County district judge, former assistant prosecutor dies after bout with cancer. ‘A voice for the voiceless’

August 18, 2021 | msn.com

Northampton County district judge dies after long bout with cancer

See More Headlines

Receive VTAE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (VTAE) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:VTAE
CUSIP: N/A
CIK: 1157602
Web: ir.vitaepharma.com
Phone: +1-215-4612000
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

VTAE Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (VTAE) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (VTAE) investors own include Bausch Health Companies (BHC), Mallinckrodt (MNK), Zosano Pharma (ZSAN), Akari Therapeutics (AKTX), Aquinox Pharmaceuticals (AQXP), Sangamo Therapeutics (SGMO), Trevena (TRVN) and Arbutus Biopharma (ABUS).

This page (NASDAQ:VTAE) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(VTAE) (VTAE) Stock Price, News & Analysis

About (VTAE) Stock (NASDAQ:VTAE)

VTAE Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

VTAE Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info